Literature DB >> 34474113

Pro-angiogenic effect of PC-3 exosomes in endothelial cells in vitro.

Anne Natalie Prigol1, Michele Patrícia Rode1, Adny Henrique Silva1, Júlia Cisilotto1, Tânia Beatriz Creczynski-Pasa2.   

Abstract

The progression to a castration-resistant prostate cancer can occur after treatment with androgen deprivation therapy, resulting in poor prognosis and ineffective therapy response. Hormone dependence transition has been associated with increased tumor vascularization. Considering that exosomes are important components in communication between tumor cells and the microenvironment, we examined the angiogenic potential of exosomes released from Pca cell lines with distinctive profiles of androgen response through exosomes isolation, microscopy and uptake, functional assays follow up by microarray, RT-qPCR and bioinformatics analysis. HUVEC cells treated with PC-3 exosomes (androgen independent) showed increased invasion and tube formation ability. In order to identify microRNAs (miRNAs) related to the angiogenic response, the characterization of exosomal miRNA profile was performed. As result we suggest that the miR-27a-3p could be involved in the pro-angiogenic effect of PC-3 exosomes.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Castration resistance; Exosomes; Prostate cancer; miRNA

Mesh:

Substances:

Year:  2021        PMID: 34474113     DOI: 10.1016/j.cellsig.2021.110126

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  2 in total

1.  Urine Cell-Free MicroRNAs in Localized Prostate Cancer Patients.

Authors:  Yoko Koh; Matias A Bustos; Jamie Moon; Rebecca Gross; Romela Irene Ramos; Suyeon Ryu; Jane Choe; Selena Y Lin; Warren M Allen; David L Krasne; Timothy G Wilson; Dave S B Hoon
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

Review 2.  Molecular mechanisms and clinical applications of exosomes in prostate cancer.

Authors:  Xiaolin Cui; Qiang Fu; Xueying Wang; Pengcheng Xia; Xianglun Cui; Xiaohui Bai; Zhiming Lu
Journal:  Biomark Res       Date:  2022-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.